Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -257,998 | -227,318 | -151,529 | -99,689 | -409,125 |
| Depreciation Amortization | 20,021 | 15,046 | 10,050 | 4,788 | 19,168 |
| Accounts receivable | 17,636 | 29,384 | 56,813 | 103,277 | -128,345 |
| Accounts payable and accrued liabilities | -11,736 | -38,677 | -29,013 | -42,948 | 29,179 |
| Other Working Capital | 80,284 | 36,356 | 81,731 | 53,189 | -115,955 |
| Other Operating Activity | 212,771 | 162,414 | 7,366 | -33,696 | 273,741 |
| Operating Cash Flow | $60,979 | $-22,795 | $-24,582 | $-15,079 | $-331,336 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 7,957 |
| PPE Investments | -9,600 | -5,954 | -5,723 | -741 | -516 |
| Investing Cash Flow | $-9,600 | $-5,954 | $-5,723 | $-741 | $7,441 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 145,172 |
| Debt Repayment | -24,843 | -17,678 | -9,709 | -3,230 | -12,298 |
| Common Stock Issued | 98,520 | 83,842 | 29,858 | 14,574 | 368,376 |
| Common Stock Repurchased | -19,682 | -20,334 | -19,748 | -18,327 | N/A |
| Other Financing Activity | -12,894 | -13,321 | -12,937 | -12,006 | -20,875 |
| Financing Cash Flow | $41,102 | $32,508 | $-12,536 | $-18,988 | $480,376 |
| Exchange Rate Effect | -28,559 | -27,664 | -31,512 | -9,039 | 24,641 |
| Beginning Cash Position | 633,067 | 654,050 | 635,193 | 589,479 | 424,361 |
| End Cash Position | 696,989 | 630,145 | 560,841 | 545,632 | 605,482 |
| Net Cash Flow | $63,922 | $-23,905 | $-74,352 | $-43,847 | $181,121 |
| Free Cash Flow | |||||
| Operating Cash Flow | 60,979 | -22,795 | -24,582 | -15,079 | -331,336 |
| Capital Expenditure | -9,600 | -5,954 | -5,723 | -741 | -1,544 |
| Free Cash Flow | 51,379 | -28,749 | -30,304 | -15,819 | -332,880 |